Paragraf staff will start to move in during the first quarter of 2023 and production is expected to ramp up in the second half of the year. The initial expansion into the Huntingdon facility will ...

Paragraf’s Semiconductor Biosensor Has Multiomics Capability With the recent acquisition of Cardea Bio, a CRISPR-Chip company, Paragraf demonstrated the novel detection of both protein and RNA ...

Today, CRISPR QC announces that Paragraf, Ltd. has acquired Cardea Bio, the technology platform developer of the CRISPR-Chip - a graphene-based biosen ...

By early summer, the company said that it expected the integration to have been completed and the product roadmap enhanced and go-to-market capabilities sped up to the benefit of existing and new ...

Birmingham Uni and Paragraf get £3.4m for graphene R&D The University of Birmingham and Paragraf have received funding awards of £1.4 million from Innovate UK and £2 million from UKRI to accelerate ...

Paragraf chief executive Simon Thomas said that electronics manufacturers and developers would for the first time be able to use low-power and high-performance graphene-based electronics devices.